Epinephrine Auto-Injectors Market Outlook (2022-2032)
[301 Pages Report] The market for epinephrine auto-injectors is estimated to reach US$ 3.2 billion by 2032, up from US$ 2 billion in 2022, at a CAGR of 4.9% between 2022 and 2032.
"Increasing government and insurance agency assistance for generic drugs could drive epinephrine auto-injectorsmarket expansion."
The epinephrine auto-injector market future trends are projected to be positive. In response to changing clinical and patient demands, syringes and injectors have evolved dramatically, resulting in increased demand for epinephrine auto-injectors.
The epinephrine auto-injectorsmarket share is quickly increasing. The increased incidence of allergies among people has been a major driver of the epinephrine auto-injector market's expansion. As a result, the increasing number of persons allergic to dust, insect bites and venom, food, and food additives has propelled the demand for epinephrine auto-injectors.
The growing demand for epinephrine auto-injectors for rapid emergency response is projected to be a major epinephrine auto-injectorsmarketkey trends and opportunities driver.
However, epinephrine adverse effects such as elevated blood pressure, headache, irregular heart rhythm in certain situations, and anxiety, among others, might stifle epinephrine auto-injectorsmarketexpansion to some amount throughout the projection period.
Epinephrine is commonly used to treat life-threatening allergic responses, restore heart rhythm, and manage asthma. This is a crucial element driving demand for epinephrine auto-injectors and is projected to contribute to epinephrine auto-injectorsmarketadoption trends in the future.
An epinephrine auto-injector is a medical device used to provide epinephrine or adrenaline to treat anaphylaxis. They are offered as pre-filled auto injecting devices containing the medicine to be injected beneath the skin or into the muscle along the outer thigh, which results in escalated demand forepinephrine auto-injector and sales of epinephrine auto-injector.
The key element driving the epinephrine auto-injector marketgrowth in the high dosage sector is the rising incidence of anaphylaxis in adults, particularly among the elderly. As epinephrine is considered the first-line therapy for anaphylaxis, the rising advice of large doses for adult patients by healthcare professionals (HCP) worldwide is supporting the segment's rise in the epinephrine auto-injector market adoption trends.
Furthermore, epinephrine auto-injector marketparticipants are aiming to supply generic, low-cost medications, which is growing demand forepinephrine auto-injector treatment choices.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is the COVID-19 Impact on the Epinephrine Auto-Injectors Market?
Following the pandemic, the healthcare market for epinephrine auto-injectors is likely to rise significantly. Due to lockdowns, travel bans, and company shutdowns, the COVID-19 has had an impact on the economy and sectors of several nations, along with the epinephrine auto-injector market key trend and opportunities.
The COVID-19 issue has overwhelmed many nations' public health systems, highlighting the critical need for long-term investment in health systems. As the COVID-19 epidemic spreads, the epinephrine auto-injector market growth is projected to slow.
The life sciences industry is thriving as a result of growing demand for in-vitro diagnostic goods and expanded epinephrine auto-injector market adoption trend and epinephrine auto-injector market opportunities, and research & development efforts throughout the world.
However, the medical technology and imaging industry is seeing a reduction in sales ofepinephrine auto-injector as a result of fewer surgeries and delayed or protracted equipment procurement.
Furthermore, internet consultations with healthcare specialists are projected to increase the epinephrine auto-injector market share. Virtual consultations with healthcare specialists are projected to become the standard care delivery strategy following the pandemic.
Digital health will prosper in the next years as telehealth transforms medical delivery together with epinephrine auto-injector market future trends.
Furthermore, interrupted clinical trials and related medication launch delays are projected to pave the door for totally virtual testing in the future.
In the future years, new technologies like mRNA are predicted to emerge and disrupt the pharmaceutical sector. The epinephrine auto-injector market is projected to see greater vertical integration and collaborative partnerships to surge demand for epinephrine auto-injector market and sales of epinephrine auto-injector.
What is Propelling the Epinephrine Auto-Injectors Market?
The increasing prevalence of allergies, growing awareness about allergies, technological developments in R&D activities such as chlorofluorocarbon-free epinephrine auto-injector inhalers using hydrofluoroalkane propellant, and high demand for epinephrine auto-injector instead of conventional devices such as standard syringes are the major factors driving the epinephrine auto-injector market key trends and opportunities.
A rise in new product approvals and new product launches by leading epinephrine auto-injector market legacy players is projected to fuel the epinephrine auto-injector market during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
What Restraints the Epinephrine Auto-Injectors Market?
Adverse side effects of excessive epinephrine auto-injector use, such as cardiac arrhythmia, pulmonary edoema, vomiting, brain haemorrhage, and so on, might represent an epinephrine auto-injector market issue.
However, regulatory barriers and hefty expenses limit the epinephrine auto-injector marketexpansion.
The epinephrine auto-injector marketgrowth is projected to be hampered by a rise in the demand for alternate medication administration routes and the introduction of nasal epinephrine sprays.
The development of epinephrine auto-injector for diverse drug viscosities, as well as a lack of sufficient training for operating auto-injectors, is expected to provide challenges to the epinephrine auto-injector market adoption trends.
What are the Trends in the Epinephrine Auto-Injectors Market?
During the projection period, a high number of patient assistance programmes and the development of novel products by leading suppliers give multiple chances for epinephrine auto-injector marketexpansion.
Drug distribution has been an important aspect in increasing people's quality of life in recent years. Syringes and injectors have developed significantly in response to evolving clinical and patient needs. As disposable drug injectors are more convenient to use than previous techniques, they have provided possibilities for epinephrine auto-injector drug makers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Comparative View of Adjacent Epinephrine Auto-Injectors Market
Epinephrine Auto-Injectors Market:
Attributes
Epinephrine Auto-Injectors Market
CAGR (2022-2032)
4.9%
Market Value (2026)
US$ 2.54 Billion
Growth Factor
One of the primary factors fueling the growth of the auto injectors market is the increasing frequency of targeted treatments.
Opportunity
The spike in investments in the form of funding and grants for therapies related with auto injectors accelerates market expansion.
Key Trends
The growing desire for self-administration will further extend the auto injectors industry.
Wearable Injectors Market:
Attributes
Wearable Injectors Market
CAGR (2022-2032)
9.9%
Market Value (2026)
USD 12.75 Billion
Growth Factor
COVID-19 has resulted in a shift in healthcare delivery toward homecare.
Opportunity
Increasing demand for biologics and monoclonal antibodies
Key Trends
During this epidemic, the use of wearable injectors for the administration of cancer medications and other maintenance treatments that are now in clinical studies has gained traction.
Contrast Media Injectors Market:
Attributes
Contrast Media Injectors Market
CAGR (2022-2032)
7.4%
Market Value (2026)
USD 2.19 billion
Growth Factor
As the number of cancer and CVD patients rises, so will the demand for better healthcare facilities and advanced diagnostic imaging methods, driving the market for contrast media injectors.
Opportunity
A substantial number of contrast agent approvals
Key Trends
Government organisations' rising investments, finances, and grants are propelling the contrast media injectors industry forward.
What is the Segmentation Outlook of the Epinephrine Auto-Injectors Market?
The epinephrine auto-injector market is divided into dosage, age group, end user, and geographical segments.
The epinephrine auto-injector market is divided into three dose levels: 0.15mg, 0.3mg, and others.
The epinephrine auto-injector market is divided into three age groups: 0-4 Years, 5-14 Years, 15-24 Years, 25-49 Years, 50-64 Years, and Above 65 Years.
The epinephrine auto-injector market is split into hospitals, clinics, and home care based on end user. Geographically, the epinephrine auto-injector market has been examined in North America, Europe, Asia-Pacific, MEA, Latin America, and the Caribbean.
Which is the Leading Segment in the Epinephrine Auto-Injectors Market by Dosage?
The global epinephrine auto-injector market may be classified into three segments based on dosage--0.15 mg, 0.30 mg, and 0.50 mg.
During the forecast period, the 0.30 mg sector of the worldwide epinephrine auto-injector marketfuture trends is expected to increase rapidly.
During the projection period, the category is likely to be driven by an increase in the volume sales of epinephrine auto-injectors.
Which is the Leading Segment in the Epinephrine Auto-Injectors Market by End User?
The global epinephrine auto-injector market may be divided into hospitals, clinics, home care, and others based on end-user.
During the projected period, the home care segment of epinephrine auto-injector market is likely to present considerable prospects.
During the projection period, the home care segment is likely to be driven by an increase in demand for self-management of anaphylaxis.
Which is the Leading Region in the Epinephrine Auto-Injectors Market?
Regions
CAGR (2022-2032)
United States
4.7%
United Kingdom
3.6%
China
4.2%
Japan
3.3%
South Korea
2.8%
The worldwide epinephrine auto-injector market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. During the forecast period, North America is expected to lead the worldwide epinephrine auto-injector market.
The market for epinephrine auto-injectors is dominated by North America. This business is thriving in this region as a result of the increased use of more expensive auto-injectors over traditional injecting techniques, as well as enhanced healthcare facilities.
Whereas Asia Pacific is expected to develop at the fastest CAGR during the forecast period due to an increase in the number of individuals suffering from allergies and increased awareness of auto-injectors among end-users. Rapid epinephrine auto-injector market growth may be witnessed in nations such as China and India.
The rising number of people suffering from various types of allergies, the availability of low-cost generic epinephrine auto-injectors, and the high rate of adoption of epinephrine auto-injectors in the United States are expected to drive the regional epinephrine auto-injector marketshare during the forecast period.
According to research published in the JAMA Network 2019, roughly 10.8% of adults in the United States, or more than 26 million people, are food allergic; yet, approximately 19% of persons believe they have a food allergy.
How Competition Influences the Epinephrine Auto-Injectors Market?
Adamis Pharmaceuticals Corporation, Alk-Abello A/S, Impax Laboratories, Inc., Mylan N.V., and Antares Pharma are among the leading players in epinephrine auto-injector market.
To acquire a competitive advantage in the epinephrine auto-injector market, the epinephrine auto-injector market’s top companies are working on extending their client base. As a result, suppliers are embarking on a number of strategic activities, including collaborations, acquisitions & mergers, and partnerships.
Recent Developments
NEW LAUNCHES:
Alerje Inc., a food allergy management firm located in Detroit, developed a smartphone case with an auto-injector that swiftly administers epinephrine for severe allergic responses in June 2021. When a dosage is removed from the case, the Alerje smartphone app will instantly change the patients' support circle.
Antares Pharma (US) struck an arrangement with Lunatus Global Medical Supplies in August 2020. (Dubai). Antares will deliver packaged goods to Lunatus under this arrangement, and Lunatus will submit and get regulatory permission for XYOSTED in the UAE and Saudi Arabia, as well as promote, market, and distribute XYOSTED in these two countries.
Teva Pharmaceuticals gained FDA permission in August 2018 to commercialise its generic epinephrine auto-injector in two strengths, 0.3 mg and 0.15 mg, in the United States.
ACQUISITION:
SHL Medical (Switzerland) bought Weibel CDS in March 2020. (Switzerland). The goal of this purchase was to increase SHL Medical's capacity to develop more sophisticated medication delivery systems based on human-centered designs and functionality.
EXTENSION:
Eli Lilly spent USD 470 million and generated approximately 460 new jobs in Durham, NC in January 2020. With this extension, North Carolina's research triangle park gained a new state-of-the-art pharmaceutical production plant.
Becton, Dickinson and Company (US) introduced a disposable autoinjector, the BD Intevia 1ml Disposable Auto-injector, in November 2019. This action will help to expand the company's auto-injector portfolio.
What is the CAGR of the Epinephrine Auto-Injectors Market?
The epinephrine auto-injectors market is projected to have a CAGR of 4.9% in 2032.
Which is the Leading Region in the Epinephrine Auto-Injectors Market?
United States is the leading region in the epinephrine auto-injectors market, with an anticipated CAGR of 4.7% by 2032.
Which Segment Leads in the Epinephrine Auto-Injectors Market by End User?
Hospital leads the epinephrine auto-injectors market with the projected CAGR of 4.8% by 2032.
What is the Growth Estimated for the Epinephrine Auto-Injectors Market by 2032?
The epinephrine auto-injectors market is predicted to grow US$ 3.2 Billion by 2032.
Which Segment Leads in the Epinephrine Auto-Injectors Market by Dosage?
0.3 mg led the epinephrine auto-injectors market with the projected CAGR of 4.9% by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Epinephrine Auto-Injectors
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Epinephrine Auto-Injectors Market, by Key Countries
4.2. Epinephrine Auto-Injectors Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Epinephrine Auto-Injectors Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Epinephrine Auto-Injectors Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By End-User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By End-User, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2022-2032
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Home Based
8.3.4. Others
8.4. Market Attractiveness Analysis By End-User
9. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Dosage
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Dosage, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage, 2022-2032
9.3.1. 0.15 mg
9.3.2. 0.3 mg
9.3.3. Others
9.4. Market Attractiveness Analysis By Dosage
10. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Age Group
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2022-2032
10.3.1. 0-4 Years
10.3.2. 5-14 Years
10.3.3. 15-24 Years
10.3.4. 25-49 Years
10.3.5. 50-64 Years
10.3.6. Above 65 Years
10.4. Market Attractiveness Analysis By Age Group
11. Global Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By End-User
12.4.3. By Age Group
12.4.4. By Dosage
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By End-User
12.5.3. By Age Group
12.5.4. By Dosage
13. Latin America Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By End-User
13.4.3. By Age Group
13.4.4. By Dosage
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By End-User
13.5.3. By Age Group
13.5.4. By Dosage
14. Europe Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By End-User
14.4.3. By Age Group
14.4.4. By Dosage
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By End-User
14.5.3. By Age Group
14.5.4. By Dosage
15. Asia Pacific Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By End-User
15.4.3. By Age Group
15.4.4. By Dosage
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By End-User
15.5.3. By Age Group
15.5.4. By Dosage
16. Middle East and Africa Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By End-User
16.4.3. By Age Group
16.4.4. By Dosage
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By End-User
16.5.3. By Age Group
16.5.4. By Dosage
17. Key Countries Epinephrine Auto-Injectors Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Epinephrine Auto-Injectors Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By End-User
17.2.2.2. By Age Group
17.2.2.3. By Dosage
17.3. Canada Epinephrine Auto-Injectors Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By End-User
17.3.2.2. By Age Group
17.3.2.3. By Dosage
17.4. Mexico Epinephrine Auto-Injectors Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By End-User
17.4.2.2. By Age Group
17.4.2.3. By Dosage
17.5. Brazil Epinephrine Auto-Injectors Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By End-User
17.5.2.2. By Age Group
17.5.2.3. By Dosage
17.6. Germany Epinephrine Auto-Injectors Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By End-User
17.6.2.2. By Age Group
17.6.2.3. By Dosage
17.7. France Epinephrine Auto-Injectors Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By End-User
17.7.2.2. By Age Group
17.7.2.3. By Dosage
17.8. Italy Epinephrine Auto-Injectors Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By End-User
17.8.2.2. By Age Group
17.8.2.3. By Dosage
17.9. BENELUX Epinephrine Auto-Injectors Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By End-User
17.9.2.2. By Age Group
17.9.2.3. By Dosage
17.10. UK Epinephrine Auto-Injectors Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By End-User
17.10.2.2. By Age Group
17.10.2.3. By Dosage
17.11. Nordic Countries Epinephrine Auto-Injectors Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By End-User
17.11.2.2. By Age Group
17.11.2.3. By Dosage
17.12. China Epinephrine Auto-Injectors Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By End-User
17.12.2.2. By Age Group
17.12.2.3. By Dosage
17.13. Japan Epinephrine Auto-Injectors Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By End-User
17.13.2.2. By Age Group
17.13.2.3. By Dosage
17.14. South Korea Epinephrine Auto-Injectors Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By End-User
17.14.2.2. By Age Group
17.14.2.3. By Dosage
17.15. GCC Countries Epinephrine Auto-Injectors Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By End-User
17.15.2.2. By Age Group
17.15.2.3. By Dosage
17.16. South Africa Epinephrine Auto-Injectors Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By End-User
17.16.2.2. By Age Group
17.16.2.3. By Dosage
17.17. Turkey Epinephrine Auto-Injectors Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By End-User
17.17.2.2. By Age Group
17.17.2.3. By Dosage
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Adamis Pharmaceuticals Corporation
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Alk-Abello A/S
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Impax Laboratories, Inc.
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Mylan N.V.
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Antares Pharma
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Pfizer Inc.
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Kaleo, Inc.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Teva Pharmaceutical Industries Ltd.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Bausch + Lomb UK Ltd- Emerade
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 2: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 3: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 4: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 5: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 6: Global Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 7: Global Epinephrine Auto-Injectors Market, By Region, 2015 – 2021
Table 8: Global Epinephrine Auto-Injectors Market, By Region, 2022 – 2032
Table 9: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 10: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 11: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 12: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 13: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 14: North America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 15: North America Epinephrine Auto-Injectors Market, By Country, 2015 – 2021
Table 16: North America Epinephrine Auto-Injectors Market, By Country, 2022 – 2032
Table 17: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 18: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 19: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 20: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 21: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 22: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 23: Latin America Epinephrine Auto-Injectors Market, By Country, 2015 – 2021
Table 24: Latin America Epinephrine Auto-Injectors Market, By Country, 2022 – 2032
Table 25: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 26: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 27: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 28: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 29: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 30: Europe Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 31: Europe Epinephrine Auto-Injectors Market, By Country, 2015 – 2021
Table 32: Europe Epinephrine Auto-Injectors Market, By Country, 2022 – 2032
Table 33: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 34: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 35: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 36: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 37: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 38: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 39: Asia Pacific Epinephrine Auto-Injectors Market, By Country, 2015 – 2021
Table 40: Asia Pacific Epinephrine Auto-Injectors Market, By Country, 2022 – 2032
Table 41: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2015 – 2021
Table 42: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By End-User, 2022 – 2032
Table 43: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2015 – 2021
Table 44: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Age Group, 2022 – 2032
Table 45: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2015 – 2021
Table 46: MEA Epinephrine Auto-Injectors Market Value (US$ Mn), By Dosage, 2022 – 2032
Table 47: MEA Epinephrine Auto-Injectors Market, By Country, 2015 – 2021
Table 48: MEA Epinephrine Auto-Injectors Market, By Country, 2022 – 2032
Table 49: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 50: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 51: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021
Table 52: Global Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 54: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 55: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 – 2021
Table 56: North America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 58: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 59: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021
Table 60: Latin America Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 62: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 63: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021
Table 64: Europe Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 66: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 67: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021
Table 68: Asia Pacific Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By End-User, 2015 - 2021
Table 70: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Age Group, 2022 – 2032
Table 71: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Dosage, 2015 - 2021
Table 72: MEA Epinephrine Auto-Injectors Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Epinephrine Auto-Injectors Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 4: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 5: Global Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 6: Global Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 7: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 8: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 9: Global Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 10: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 11: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 12: Global Epinephrine Auto-Injectors Market Share, By Region, 2022 & 2032
Figure 13: Global Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Epinephrine Auto-Injectors Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 16: North America Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 17: North America Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 18: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 19: North America Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 20: North America Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 21: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 22: North America Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 23: North America Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 24: North America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 25: North America Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 26: North America Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 30: Latin America Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 31: Latin America Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 32: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 33: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 34: Latin America Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 35: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 36: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 37: Latin America Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 38: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 39: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 40: Latin America Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032
Figure 41: Latin America Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 44: Europe Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 45: Europe Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 46: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 47: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 48: Europe Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 49: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 50: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 51: Europe Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 52: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 53: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 54: Europe Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032
Figure 55: Europe Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 58: MEA Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 59: MEA Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 60: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 61: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 62: MEA Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 63: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 64: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 65: MEA Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 66: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 67: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 68: MEA Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032
Figure 69: MEA Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Epinephrine Auto-Injectors Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 72: Asia Pacific Epinephrine Auto-Injectors Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 73: Asia Pacific Epinephrine Auto-Injectors Market Share, By End-User, 2022 & 2032
Figure 74: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 75: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By End-User – 2022-2032
Figure 76: Asia Pacific Epinephrine Auto-Injectors Market Share, By Age Group, 2022 & 2032
Figure 77: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Age Group – 2022-2032
Figure 78: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Age Group – 2022-2032
Figure 79: Asia Pacific Epinephrine Auto-Injectors Market Share, By Dosage, 2022 & 2032
Figure 80: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Dosage – 2022-2032
Figure 81: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Dosage – 2022-2032
Figure 82: Asia Pacific Epinephrine Auto-Injectors Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Epinephrine Auto-Injectors Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Epinephrine Auto-Injectors Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: US Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 87: US Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 88: US Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 89: Canada Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 90: Canada Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 91: Canada Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 92: Canada Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 93: Brazil Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 94: Brazil Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 95: Brazil Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 96: Brazil Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 97: Mexico Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: Mexico Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 99: Mexico Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 100: Mexico Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 101: Germany Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 102: Germany Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 103: Germany Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 104: Germany Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 105: U.K. Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 106: U.K. Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 107: U.K. Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 108: U.K. Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 109: France Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: France Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 111: France Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 112: France Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 113: Italy Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 114: Italy Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 115: Italy Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 116: Italy Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 117: BENELUX Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 118: BENELUX Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 119: BENELUX Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 120: BENELUX Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 121: Nordic Countries Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 123: Nordic Countries Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 124: Nordic Countries Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 125: China Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 126: China Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 127: China Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 128: China Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 129: Japan Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 130: Japan Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 131: Japan Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 132: Japan Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 133: South Korea Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 134: South Korea Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 135: South Korea Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 136: South Korea Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 137: GCC Countries Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 139: GCC Countries Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 140: GCC Countries Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 141: South Africa Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 142: South Africa Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 143: South Africa Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 144: South Africa Epinephrine Auto-Injectors Market Share, By Dosage, 2021
Figure 145: Turkey Epinephrine Auto-Injectors Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 146: Turkey Epinephrine Auto-Injectors Market Share, By End-User, 2021
Figure 147: Turkey Epinephrine Auto-Injectors Market Share, By Age Group, 2021
Figure 148: Turkey Epinephrine Auto-Injectors Market Share, By Dosage, 2021
